Your browser doesn't support javascript.
loading
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
Linette, Gerald P; Becker-Hapak, Michelle; Skidmore, Zachary L; Baroja, Miren Lorea; Xu, Chong; Hundal, Jasreet; Spencer, David H; Fu, Weixuan; Cummins, Casey; Robnett, Maya; Kaabinejadian, Saghar; Hildebrand, William H; Magrini, Vincent; Demeter, Ryan; Krupnick, Alexander S; Griffith, Obi L; Griffith, Malachi; Mardis, Elaine R; Carreno, Beatriz M.
Afiliación
  • Linette GP; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Becker-Hapak M; The Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Skidmore ZL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Baroja ML; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Xu C; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110.
  • Hundal J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
  • Spencer DH; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
  • Fu W; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110.
  • Cummins C; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
  • Robnett M; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110.
  • Kaabinejadian S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Hildebrand WH; The Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Magrini V; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Demeter R; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Krupnick AS; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Griffith OL; The Parker Institute for Cancer Immunotherapy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Griffith M; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Mardis ER; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Carreno BM; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110.
Proc Natl Acad Sci U S A ; 116(47): 23662-23670, 2019 11 19.
Article en En | MEDLINE | ID: mdl-31685621
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Melanoma / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Linfocitos Infiltrantes de Tumor / Linfocitos T CD8-positivos / Melanoma / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos